Exclusion Criteria:~* â€¢ Significant neurodegenerative diseases and causes of dementia, other than AD,
including Parkinson's disease and Huntington's disease, vascular dementia, CJD (Creutzfeldt-Jakob disease), LBD
(Lewy Body dementia), PSP (Progressive Supranuclear Palsy), AIDS (Acquired Immunodeficiency Syndrome), or NPH
(normal pressure hydrocephalus)~* Meeting Diagnostic Criteria for Possible AD according to workgroups of the
Diagnostic Guidelines of the NIA-AA~* Hepatic impairment defined as Child-Pugh class A or more severe liver
impairment~* History of moderate or severe skin reactions to medications or current moderate or severe disease
of the skin and subcutaneous tissues~* History of a major depressive episode within the past 6 months of
screening~* History of diagnosis of schizophrenia~* History of uncontrolled bipolar disorder within past five
years of screening~* History of seizures within past two years of screening~* Contraindication to lumbar
puncture and MRI~* Participation in another clinical trial for an investigational agent and having taken at
least one dose of study drug, unless confirmed as having been on placebo, within 90 days prior to the baseline
visit. The end of a previous investigational trial is defined as the date of the last dose of an
investigational agent.
